Malic Acid Supplementation Combined With Immunotherapy in Patients With Solid Tumors
Clinical trial NCT07325123 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07325123
- Sponsor
- The First Affiliated Hospital of Xinxiang Medical College
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-31
- Primary completion
- 2027-12-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.